These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16312527)

  • 41. Comparative bioavailability of two oral formulations of ciprofloxacin.
    Trejo D; Toledo A; Carrasco-Portugal Mdel C; Aguilar-Cota ME; Herrera JE; Flores-Murrieta FJ
    Proc West Pharmacol Soc; 2003; 46():134-5. PubMed ID: 14699910
    [No Abstract]   [Full Text] [Related]  

  • 42. A study of ciprofloxacin kinetics in human muscle and gut tissues.
    Viell B; Vestweber KH; Scholl H; Schaaf S
    J Chemother; 1989 Jul; 1(4 Suppl):575-6. PubMed ID: 16312539
    [No Abstract]   [Full Text] [Related]  

  • 43. Distribution of ciprofloxacin in the isolated rat lung in the presence and absence of tissue oedema.
    Reinoso RF; Sánchez-Navarro A; Lanao JM
    Eur J Pharm Sci; 1999 Jul; 8(3):203-9. PubMed ID: 10379043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tissue penetration and metabolism of ciprofloxacin.
    Wise R; Donovan IA
    Am J Med; 1987 Apr; 82(4A):103-7. PubMed ID: 3578319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ciprofloxacin and oxociprofloxacin pharmacokinetics in patients on haemodialysis.
    Drinovec J; Mrhar A; Bren A; Primozic S; Karba R; Varl J; Kozjek F
    J Chemother; 1989 Jul; 1(4 Suppl):565-6. PubMed ID: 16312534
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of chloroquine on the bioavailability of ciprofloxacin in man.
    Ilo EC; Orisakwe OE; Ilondu NA; Okwoli N; Brown SA; Elo-Ilo J; Agbasi PU
    J Control Release; 2006 Nov; 116(2):e109-10. PubMed ID: 17718943
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparative assessment of the pharmacokinetics and pharmacodynamics of ciprofloxacin after single i.v. doses of 200 and 400mg.
    Garraffo R; Drugeon HB
    Drugs; 1995; 49 Suppl 2():317-20. PubMed ID: 8549347
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparative scintigraphic study of 99mTc ciprofloxacin pharmacokinetics after intravenous and lymphotropic administration in experimental pulmonary suppuration.
    Lishmanov YB; Sazonova SI; Sokolovich EG; Chernov VI
    Bull Exp Biol Med; 2005 Jan; 139(1):94-7. PubMed ID: 16142288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers.
    Wingender W; Graefe KH; Gau W; Förster D; Beermann D; Schacht P
    Eur J Clin Microbiol; 1984 Aug; 3(4):355-9. PubMed ID: 6489326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ciprofloxacin--clincal and pharmacokinetic studies in ear, nose and throat infections.
    Federspil P; Koch A; Tiesler E
    J Chemother; 1989 Jul; 1(4 Suppl):556-8. PubMed ID: 16312530
    [No Abstract]   [Full Text] [Related]  

  • 51. Efficient drug delivery to lung epithelial lining fluid by aerosolization of ciprofloxacin incorporated into PEGylated liposomes for treatment of respiratory infections.
    Chono S; Suzuki H; Togami K; Morimoto K
    Drug Dev Ind Pharm; 2011 Apr; 37(4):367-72. PubMed ID: 20815792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New approach for accurate simulation of human pharmacokinetics in an in vitro pharmacodynamic model: application to ciprofloxacin.
    Ba BB; Bernard A; Iliadis A; Quentin C; Ducint D; Etienne R; Fourtillan M; Maachi-Guillot I; Saux MC
    J Antimicrob Chemother; 2001 Feb; 47(2):223-7. PubMed ID: 11157913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Study on the bioequivalence of ciprofloxacin 500 mg orally versus 200 mg i.v.
    Garraffo R; Lapalus P; Dellamonica P; Bernard E; Etesse H
    Chemioterapia; 1987 Jun; 6(2 Suppl):298-300. PubMed ID: 3509420
    [No Abstract]   [Full Text] [Related]  

  • 54. The pharmacokinetics of sulfapyridine and its N4-acetyl-, and hydroxy metabolites in man.
    Hekster YA; Vree TB; Tijhuis MW; Termond EF
    J Chemother; 1989 Jul; 1(4 Suppl):597-9. PubMed ID: 16312549
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmacokinetic interaction of ketoconazole and itraconazole with ciprofloxacin.
    Abou-Auda HS; Mustafa AA; Al-Humayyd MS
    Biopharm Drug Dispos; 2008 Jan; 29(1):29-35. PubMed ID: 17943700
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Penetration of ciprofloxacin in the pleural fluid.
    Bölcskei P; Burkhardt G; Klatte O; Dimpel M; Thoma B; Gill E
    Chemioterapia; 1987 Jun; 6(2 Suppl):290-2. PubMed ID: 3509417
    [No Abstract]   [Full Text] [Related]  

  • 57. Lack of inhibitory effects of several fluoroquinolones on cytochrome P-450 3A activities at clinical dosage in dogs.
    Regmi NL; Abd El-Aty AM; Kubota R; Shah SS; Shimoda M
    J Vet Pharmacol Ther; 2007 Feb; 30(1):37-42. PubMed ID: 17217399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in ill cows.
    Fu LX; Jiang ZG; Ding HZ; Liu YH
    J Vet Pharmacol Ther; 2008 Jun; 31(3):240-5. PubMed ID: 18471145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
    Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circadian variation in urinary excretion of ciprofloxacin after a single-dose oral administration at 1000 and 2200 hours in human subjects.
    Rao VV; Rambhau D; Rao BR; Srinivasu P
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1802-4. PubMed ID: 9257765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.